In this episode, Dr. Michael Bass, Global Medical Director, Viome, discusses how microbiome testing and personalized nutrition can help clinicians address persistent GI symptoms, improve clinical decision making, and support earlier pancreatic cancer detection. He also explores emerging trends in AI, preventative care, and the future of clinical practice.
How Microbiome Science Is Advancing Personalized Care and Early Cancer Detection with Dr. Michael Bass
Next Up in Becker's Healthcare Podcast Episodes
-
In this episode, Amy Lynn LeDuc, Vice President and GM of Healthcare & Life Sciences, Adobe, discusses how healthcare organizations…
-
In this episode, William Teague, Managing Director, VMG Health, and Cordell Mack, Managing Director, VMG Health, discuss how private equity…
-
In this episode, Alan Condon, Editor-in-Chief at Becker’s Healthcare, joins Scott Becker to discuss major healthcare mergers and acquisitions, including…
Comments are closed.